The U.S. Food and Drug Administration (FDA) has lifted its hold on a large-scale clinical trial evaluating nexiguran ziclumeran,…
Articles by Andrea Lobo
Treatments that target the transthyretin (TTR) protein, either by stabilizing it or reducing its production, were associated with about a…
Nerve ultrasound — a scan that uses high-frequency sound waves to create real-time images of the body’s nerves — may…
RNA-targeted therapies — ones that zero in on molecules acting as messengers for genetic information in cells — are safe…
Undergoing a liver transplant and/or receiving disease-modifying treatments significantly improves survival in people with hereditary transthyretin amyloidosis (hATTR), a group…
A specialized MRI technique known as the variable echo time (vTE) sequence may help identify structural changes in nerves linked…
A higher proportion of fat in the tissue that surrounds peripheral nerves, as assessed with a noninvasive MRI scan, may…
Sudoscan, a test used to indirectly assess small nerve fiber damage through sweat gland function, may be a marker of…
Throughout 2024, Amyloidosis News Today informed our readers about the latest developments in treatment and clinical trials for…
Gly103Arg, a mutation in the TTR gene that has been exclusively reported in Chinese people, is associated with a…